BARTLETT, MARK J.,CODELLI, JULIAN ANDREW,CORKEY, BRITTON KENNETH,COSMAN, JENNIFER LEIGH,ELBEL, KRISTYNA,LOYER-DREW, JENNIFER ALISSA,SPERANDIO, DAVID,VAN VELDHUIZEN, JOSHUA,YANG, HAI,YEUNG, SUET CHUNG
申请号：
CA2985642
公开号：
CA2985642A1
申请日:
2016.05.12
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present disclosure provides indoleamine 2,3 -dioxygenase 1 (IDO1) inhibitors of Formula I: or pharmaceutically acceptable salts thereof, in which X, L, n, m, R1, R2a, R2b, Rn, Rm, and R1 are as defined herein, as well as pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts thereof, and methods of using the same to treat conditions mediated by IDO1.
